Altevax
Altevax is a Phase 2 clinical-stage biotechnology company developing a pioneering melanin-based immunotherapy platform for cancer treatment. Its patented technology enhances antigen-specific T-cell immune responses and is compatible with a broad range of peptides, with potential to complement existing immuno-oncology approaches, including anti-PD-1 therapies. Altevax’s lead program targeting TERT in glioblastoma is currently in Phase 2 clinical development. The company collaborates with leading clinical institutions, including AP-HP, and is actively fundraising and exploring strategic partnerships to accelerate development.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Altevax
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- BF
Batoul Farhat
Head of Business Development · Sales & Business Development
EmailPhone - AG
Angeline Gautrais
Ingénieure Chimiste R & d · Science
EmailPhone - EO
Emma Osswald
Stagiaire Master 2 · Other
EmailPhone - BR
Benoit Roch
Immunologist Oncologist - Project Manager · Other
EmailPhone
Showing 4 of 5 verified contacts
Top roles at Altevax
4 distinct titles indexed · top 4 shown.
- 2head of business development
- 1immunologist oncologist - project manager
- 1ingénieure chimiste r & d
- 1stagiaire master 2
Sign up to unlock all 5 contacts at Altevax
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Altevax
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.